Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of perampanel when given as an adjunctive therapy in subjects with refractory partial seizures.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00700310
Study type Interventional
Source Eisai Inc.
Contact
Status Completed
Phase Phase 3
Start date August 2008
Completion date January 2010

See also
  Status Clinical Trial Phase
Completed NCT00699582 - To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Phase 3
Completed NCT00903786 - A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) Phase 2
Completed NCT00699972 - Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Phase 3
Completed NCT00849212 - An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs) Phase 2
Withdrawn NCT04558580 - Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures Phase 3